Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

Targeted CRISPR lipid nanoparticles eliminated 50% of tumors in mice with head and neck cancer.

With so much science going on in the Huntington’s disease space, we’re bringing you a monthly recap from March 2025 to cover ...

A new CRISPR-based technology, called RIDE, is a leap forward for this trail-blazing technology. With the precision of a ...

Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells of head and neck tumors—and successfully eliminated 50% of the tumors in model animals. This study was led ...

A team of researchers at Karolinska Institutet has developed a novel tool for genetic research. The study, published in Nucleic Acids Research, introduces BLU-VIPR, a method that allows ...

In their Nobel Prize-winning work, Penn's Katalin Kariko, PhD, and Drew Weissman, MD, PhD, showed how to modify mRNA to make ...

AWS’s framework will speed up the analysis of ElevateBio’s large protein datasets, hinting at promising drug candidates.

Beam Therapeutics said Monday that it used a form of CRISPR called base editing to correct, in several patients, a mutation that drives a debilitating lung condition that may affect tens of ...